Global Antimicrobial Peptides Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Antimicrobial Peptides Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type
  • 1.4.2 Plant Antimicrobial Peptides
  • 1.4.3 Microbial Antimicrobial Peptides
  • 1.2.4 Animal Antimicrobial Peptides
• 1.3 Market by Application
  • 1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application
  • 1.3.2 Pharmaceuticals
  • 1.3.3 Feed Additives
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Antimicrobial Peptides Sales Estimates and Forecasts 2016-2027
• 2.2 Global Antimicrobial Peptides Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Antimicrobial Peptides Regions by Sales
  • 2.4.1 Global Top Antimicrobial Peptides Regions by Sales (2016-2021)
  • 2.4.2 Global Top Antimicrobial Peptides Regions by Sales (2022-2027)
• 2.5 Global Top Antimicrobial Peptides Regions by Revenue
  • 2.5.1 Global Top Antimicrobial Peptides Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Antimicrobial Peptides Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Antimicrobial Peptides Sales by Manufacturers
  • 3.1.1 Global Top Antimicrobial Peptides Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Sales in 2020
• 3.2 Global Antimicrobial Peptides Revenue by Manufacturers
  • 3.2.1 Global Top Antimicrobial Peptides Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Revenue in 2020
• 3.3 Global Antimicrobial Peptides Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Antimicrobial Peptides Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Antimicrobial Peptides Sales by Type
  • 4.1.1 Global Antimicrobial Peptides Historical Sales by Type (2016-2021)
  • 4.1.2 Global Antimicrobial Peptides Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2016-2027)
• 4.2 Global Antimicrobial Peptides Revenue by Type
  • 4.2.1 Global Antimicrobial Peptides Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Antimicrobial Peptides Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
• 4.3 Global Antimicrobial Peptides Price by Type
  • 4.3.1 Global Antimicrobial Peptides Price by Type (2016-2021)
  • 4.3.2 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Antimicrobial Peptides Sales by Application
  • 5.1.1 Global Antimicrobial Peptides Historical Sales by Application (2016-2021)
  • 5.1.2 Global Antimicrobial Peptides Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2016-2027)
• 5.2 Global Antimicrobial Peptides Revenue by Application
  • 5.2.1 Global Antimicrobial Peptides Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Antimicrobial Peptides Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
• 5.3 Global Antimicrobial Peptides Price by Application
  • 5.3.1 Global Antimicrobial Peptides Price by Application (2016-2021)
  • 5.3.2 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Antimicrobial Peptides Market Size by Type
  • 6.1.1 North America Antimicrobial Peptides Sales by Type (2016-2027)
  • 6.1.2 North America Antimicrobial Peptides Revenue by Type (2016-2027)
• 6.2 North America Antimicrobial Peptides Market Size by Application
  • 6.2.1 North America Antimicrobial Peptides Sales by Application (2016-2027)
  • 6.2.2 North America Antimicrobial Peptides Revenue by Application (2016-2027)
• 6.3 North America Antimicrobial Peptides Market Size by Country
  • 6.3.1 North America Antimicrobial Peptides Sales by Country (2016-2027)
  • 6.3.2 North America Antimicrobial Peptides Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Antimicrobial Peptides Market Size by Type
  • 7.1.1 Europe Antimicrobial Peptides Sales by Type (2017-2027)
  • 7.1.2 Europe Antimicrobial Peptides Revenue by Type (2017-2027)
• 7.2 Europe Antimicrobial Peptides Market Size by Application
  • 7.2.1 Europe Antimicrobial Peptides Sales by Application (2017-2027)
  • 7.2.2 Europe Antimicrobial Peptides Revenue by Application (2017-2027)
• 7.3 Europe Antimicrobial Peptides Market Size by Country
  • 7.3.1 Europe Antimicrobial Peptides Sales by Country (2017-2027)
  • 7.3.2 Europe Antimicrobial Peptides Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Antimicrobial Peptides Market Size by Type
  • 8.1.1 Asia Pacific Antimicrobial Peptides Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Antimicrobial Peptides Revenue by Type (2018-2027)
• 8.2 Asia Pacific Antimicrobial Peptides Market Size by Application
  • 8.2.1 Asia Pacific Antimicrobial Peptides Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Antimicrobial Peptides Revenue by Application (2018-2027)
• 8.3 Asia Pacific Antimicrobial Peptides Market Size by Region
  • 8.3.1 Asia Pacific Antimicrobial Peptides Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Antimicrobial Peptides Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Antimicrobial Peptides Market Size by Type
  • 9.1.1 Latin America Antimicrobial Peptides Sales by Type (2019-2027)
  • 9.1.2 Latin America Antimicrobial Peptides Revenue by Type (2019-2027)
• 9.2 Latin America Antimicrobial Peptides Market Size by Application
  • 9.2.1 Latin America Antimicrobial Peptides Sales by Application (2019-2027)
  • 9.2.2 Latin America Antimicrobial Peptides Revenue by Application (2019-2027)
• 9.3 Latin America Antimicrobial Peptides Market Size by Country
  • 9.3.1 Latin America Antimicrobial Peptides Sales by Country (2019-2027)
  • 9.3.2 Latin America Antimicrobial Peptides Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Antimicrobial Peptides Market Size by Type
  • 6.1.1 Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Antimicrobial Peptides Market Size by Application
  • 6.2.1 Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Antimicrobial Peptides Market Size by Country
  • 6.3.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 AnaSpec
  • 11.1.1 AnaSpec Corporation Information
  • 11.1.2 AnaSpec Overview
  • 11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 AnaSpec Antimicrobial Peptides Product Description
  • 11.1.5 AnaSpec Related Developments
• 11.2 AMP Biotech
  • 11.2.1 AMP Biotech Corporation Information
  • 11.2.2 AMP Biotech Overview
  • 11.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 AMP Biotech Antimicrobial Peptides Product Description
  • 11.2.5 AMP Biotech Related Developments
• 11.3 Phoenix Biotech
  • 11.3.1 Phoenix Biotech Corporation Information
  • 11.3.2 Phoenix Biotech Overview
  • 11.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Phoenix Biotech Antimicrobial Peptides Product Description
  • 11.3.5 Phoenix Biotech Related Developments
• 11.4 Novabiotics
  • 11.4.1 Novabiotics Corporation Information
  • 11.4.2 Novabiotics Overview
  • 11.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Novabiotics Antimicrobial Peptides Product Description
  • 11.4.5 Novabiotics Related Developments
• 11.5 Chinese Peptide
  • 11.5.1 Chinese Peptide Corporation Information
  • 11.5.2 Chinese Peptide Overview
  • 11.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Chinese Peptide Antimicrobial Peptides Product Description
  • 11.5.5 Chinese Peptide Related Developments
• 11.6 Ontores
  • 11.6.1 Ontores Corporation Information
  • 11.6.2 Ontores Overview
  • 11.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Ontores Antimicrobial Peptides Product Description
  • 11.6.5 Ontores Related Developments
• 11.7 GenScript
  • 11.7.1 GenScript Corporation Information
  • 11.7.2 GenScript Overview
  • 11.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 GenScript Antimicrobial Peptides Product Description
  • 11.7.5 GenScript Related Developments
• 11.8 Hycult Biotech
  • 11.8.1 Hycult Biotech Corporation Information
  • 11.8.2 Hycult Biotech Overview
  • 11.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Hycult Biotech Antimicrobial Peptides Product Description
  • 11.8.5 Hycult Biotech Related Developments
• 11.9 Sunsmile
  • 11.9.1 Sunsmile Corporation Information
  • 11.9.2 Sunsmile Overview
  • 11.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Sunsmile Antimicrobial Peptides Product Description
  • 11.9.5 Sunsmile Related Developments
• 11.10 Ruixing Biotechnology
  • 11.10.1 Ruixing Biotechnology Corporation Information
  • 11.10.2 Ruixing Biotechnology Overview
  • 11.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Description
  • 11.10.5 Ruixing Biotechnology Related Developments
• 11.1 AnaSpec
  • 11.1.1 AnaSpec Corporation Information
  • 11.1.2 AnaSpec Overview
  • 11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 AnaSpec Antimicrobial Peptides Product Description
  • 11.1.5 AnaSpec Related Developments
• 11.12 Glam Technology
  • 11.12.1 Glam Technology Corporation Information
  • 11.12.2 Glam Technology Overview
  • 11.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Glam Technology Product Description
  • 11.12.5 Glam Technology Related Developments
• 11.13 ProteLight Pharmaceutical & Biotechnology
  • 11.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
  • 11.13.2 ProteLight Pharmaceutical & Biotechnology Overview
  • 11.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 ProteLight Pharmaceutical & Biotechnology Product Description
  • 11.13.5 ProteLight Pharmaceutical & Biotechnology Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Antimicrobial Peptides Value Chain Analysis
• 12.2 Antimicrobial Peptides Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Antimicrobial Peptides Production Mode & Process
• 12.4 Antimicrobial Peptides Sales and Marketing
  • 12.4.1 Antimicrobial Peptides Sales Channels
  • 12.4.2 Antimicrobial Peptides Distributors
• 12.5 Antimicrobial Peptides Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Antimicrobial Peptides Industry Trends
• 13.2 Antimicrobial Peptides Market Drivers
• 13.3 Antimicrobial Peptides Market Challenges
• 13.4 Antimicrobial Peptides Market Restraints

14 Key Findings in The Global Antimicrobial Peptides Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details